NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma
17th December 2021 Uncategorised 0The approval follows a successful period of monitoring and patient access through the Cancer Drugs Fund.
More: NICE recommends monotherapy for adjuvant treatment of stage 3 melanoma
Source: News
